Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Recruiting
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Angiokeratomas (LOTU)
NCT07552077· Phase 2· Palvella Therapeutics, Inc.· Source
Contact: Graham Lichtman, MD
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error